NASDAQ
Cynata Therapeutics Limited (CYYNF) has a current ratio of 4.40x as of Monday, May 25, 2026. This represents a 55.35% decrease compared to its 12-month average of 9.85x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.